Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Clotrimazole may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for This medicinal product contains Clotrimazole which belongs to a group of medicines called azoles and is an anti-fungal agent which fights the cause of infections such as vaginal thrush. Clotrimazole 500mg vaginal tablet is a single application for the treatment of vaginal thrush (candidal vaginitis). It is inserted into the vagina for treatment at the site of infection (see section 3, "How to use Clotrimazole"). Only use this product if you have been previously diagnosed by your doctor as having vaginal thrush.
e Clotrimazole Do not use Clotrimazole:
Page 1 of 4
Do not use tampons, intravaginal douches (vaginal washes/cleansers), spermicides or other vaginal products while using this product. Avoid vaginal intercourse while you have thrush and during use of this product because your partner could become infected. Other medicines and Clotrimazole Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This includes herbal medicines. Inform your doctor if you are taking tacrolimus or sirolimus (used to reduce the immune response to prevent rejection after an organ transplant). Pregnancy and Breast-feeding Clotrimazole vaginal tablet can be used in pregnancy and breastfeeding. If you are pregnant or think you may be pregnant, ask your doctor or midwife for advice before using this medicinal product. If you have informed your doctor or midwife, follow their instructions carefully. To treat internal thrush, your doctor may recommend that you insert the vaginal tablet without the help of the applicator. Clotrimazole contains lactose If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before using this medicinal product.
Clotrimazole If this medicinal product has been prescribed for you by your doctor, follow any instructions they may have given to you. If you purchased this product without a prescription, follow these directions closely. Check with your doctor or pharmacist if you are not sure. •
Treatment consists of one vaginal tablet, which should be inserted into the vagina at night.
Instructions how to insert Clotrimazole Vaginal Tablet
•
Carefully insert the applicator into the vagina as deeply as is comfortable. This is easiest when lying on your back with your legs slightly bent (Diagram 2)
Page 2 of 4
•
Holding the applicator "B" in place, slowly and carefully push the inner plunger "A" as far as it will go so the tablet is deposited into the vagina (Diagram 3)
•
Remove the disposable applicator from the vagina and dispose of it safely, out of the reach of children. The applicator cannot be flushed down the toilet.
Since the tablet dissolves in the vagina, it is quite common to notice a white chalky residue after using. This does not mean that the treatment has not worked. However, if you notice pieces of undissolved tablet, speak to your doctor or a pharmacist, as the treatment may not have worked properly. Duration of treatment
Like all medicines, this medicinal product can cause side effects, although not everybody gets them. Seek medical advice immediately if you develop the following symptoms:
Page 3 of 4
Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow card Scheme at www.mhra.gov.uk/yellowcard or search for Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicinal product.
Clotrimazole
What Clotrimazole Vaginal Tablets contains: Each 500mg vaginal tablet contains 500mg Clotrimazole. The other ingredients are: Adipic acid, microcrystalline cellulose, pre-gelatinised maize starch, sodium hydrogen carbonate, stearic acid, lactose, polysorbate 80, magnesium stearate, maize starch, colloidal silicon dioxide What Clotrimazole Vaginal Tablets look like and the contents of the pack: Clotrimazole vaginal tablets are white, oblong uncoated vaginal tablets with "500" debossed on one side and plain on the other. The pack contains 1 vaginal tablet with a disposable applicator. Marketing Authorisation Holder and Manufacturer: Tillomed Laboratories Ltd. 220 Butterfield Great Marlings Luton LU2 8DL UK Product Licence Number: PL 11311/0042 This leaflet was last revised in January 2023 Till-Ver 8.1
Page 4 of 4
Clotrimazole 500mg Vaginal Tablet comes as tablet containing 500mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Clotrimazole 500mg Vaginal Tablet is clotrimazole.
This leaflet reproduces the patient information leaflet approved for Clotrimazole 500mg Vaginal Tablet, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Clotrimazole vaginal tablets are indicated for the treatment of candidal vaginitis.
Posology
The treatment consists of one vaginal tablet to be inserted at night, using the applicator provided.
Method of administration
One 500mg tablet should be placed into the holder of the applicator. The applicator should be inserted as high as possible into the vagina. This is best achieved when lying back with legs bent up. The plunger is slowly pushed in as far as it will go depositing the tablet in the vagina. The applicator should then be removed from the vagina and disposed of carefully, out of the reach of children. A second treatment may be carried out if necessary.
Clotrimazole vaginal tablets need moisture in the vagina in order to dissolve completely, otherwise undissolved pieces of the tablets might crumble out of the vagina. Pieces of undissolved tablets may be noticed by women who experience vaginal dryness. To help prevent this it is important that the tablet is inserted as high as possible into the vagina at bedtime.
Treatment should not be performed during menstrual period due to the risk of the tablets being washed out by the menstrual flow. The treatment should be finished before the onset of menstruation.
Do not use tampons, intravaginal douches, spermicides or other vaginal products while using this product.
Vaginal intercourse should be avoided in case of vaginal infection and while using this product because the partner could become infected.
Children: Not for use in children under 16 years of age.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
Medical advice should be sought if this is the first time the patient has experienced symptoms of candidal vaginitis.
Before using Clotrimazole vaginal tablet, medical advice must be sought if any of the following are applicable:
• more than two infections of candidal vaginitis in the last 6 months.
• previous history of sexually transmitted disease or exposure to partner with sexually transmitted disease.
• pregnancy or suspected pregnancy.
• aged under 16 or over 60 years.
• known hypersensitivity to imidazoles or other vaginal antifungal products.
Clotrimazole vaginal tablet should not be used if the patient has any of the following symptoms where upon medical advice should be sought:
• irregular vaginal bleeding.
• abnormal vaginal bleeding or a blood-stained discharge.
• vulval or vaginal ulcers, blisters or sores.
• lower abdominal pain or dysuria.
• any adverse events such as redness, irritation or swelling associated with the treatment.
• fever or chills.
• nausea or vomiting.
• diarrhoea.
• foul smelling vaginal discharge.
Patients should be advised to consult their physician if the symptoms have not been relieved within one week of using Clotrimazole vaginal tablet. Clotrimazole vaginal tablet can be used again if the candidal infection returns after 7 days. However, if the candidal infection recurs more than twice within six months, patients should be advised to consult their physician.
When used in pregnancy, the pessary should be inserted without using an applicator (see “Pregnancy”).
Laboratory tests have suggested that, when used together, this product may cause damage to latex contraceptives. Consequently the effectiveness of such contraceptives may be reduced. Patients should be advised to use alternative precautions for at least five days after using this product.
Concomitant medication with Clotrimazole vaginal tablet and oral tacrolimus (FK-506; immunosuppressant) might lead to increased tacrolimus plasma levels and similarly with sirolimus. Patients should thus be closely monitored for signs and symptoms of tacrolimus or sirolimus overdosage, if necessary by determination of the respective plasma levels.
Fertility:
No human studies of the effects of clotrimazole on fertility have been performed; however, animal studies have not demonstrated any effects of the drug on fertility.
Pregnancy:
There are limited amount of data from the use of clotrimazole in pregnant women. Animal studies with clotrimazole have shown reproductive toxicity at high oral doses (see section 5.3). At the low systemic exposures of clotrimazole following vaginal treatment, harmful effects with respect to reproductive toxicity are not predicted.
Clotrimazole can be used during pregnancy, but only under the supervision of a physician or midwife.
During pregnancy, the vaginal tablet should be inserted without using an applicator.
Breast-feeding:
There are no data on the excretion of clotrimazole into human milk. However, systemic absorption is minimal after administration and is unlikely to lead to systemic effects. Clotrimazole may be used during lactation.
This medication has no or negligible influence on the ability to drive or use machinery.
Frequency not known. As the listed undesirable effects are based on spontaneous reports, assigning accurate frequency of occurrence for each is not possible.
Immune system disorders:
Anaphylactic reaction, angioedema, hypersensitivity.
Vascular disorder:
syncope, hypotension.
Respiratory, thoracic and mediastinal disorders:
dyspnea.
Gastrointestinal disorders:
abdominal pain, nausea
Skin and Subcutaneous Tissue Disorders:
Rash, urticaria, pruritus.
Reproductive system and breast disorders:
Vaginal exfoliation, vaginal discharge, vaginal haemorrhage, vulvovaginal discomfort, vulvovaginal erythema, vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal pain.
General disorders and administration site conditions: application site irritation, oedema, pain.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
No risk of acute intoxication is seen as it is unlikely to occur following a single vaginal or dermal application of an overdose (application over a large area under conditions favourable to absorption) or inadvertent oral ingestion. There is no specific antidote.
In the event of accidental oral ingestion, gastric lavage is rarely required and should be considered only if clinical symptoms of overdose become apparent (e.g. dizziness, nausea or vomiting). Gastric lavage should be carried out only if the airway can be protected adequately.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Clotrimazole 500mg Vaginal Tablet. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.